Thoracic surgery
Conditions
Interventions
Group 2:0.5% ropivacaine 28ml + dexmedetomidine 1ug/kg
Group 3:0.5% ropivacaine 28ml+ ?nalbuphine 20mg
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ASA I-III, aged 18-75 years old, normal cognitive function, can cooperate with the completion of the experiment.
Exclusion criteria
Exclusion criteria: 1) coagulation dysfunction; 2) puncture point infections; 3) allergic to local anesthetics or opioids; 4) analgesic drug addicts; 5) refusal of ESP blockade; 6) chronic pain, mental or nervous system disease; 7) serious disease of heart head blood-vessel, liver and kidney function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores in static and dynamic conditions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the block;The first time of effective pressing of electronic analgesia pump;Effective pressing times of electronic analgesia pump;Medication in operation;Complications such as nauseas?vomiting and pneumonia;postoperative hospitalization time;The dosage of analgesics added at the ward; | — |
Countries
China
Contacts
Public ContactLi Yuanhai
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed